These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31883661)

  • 1. Intracranial calcifications under vitamin K antagonists or direct oral anticoagulants: Results from the French VIKING study in older adults.
    Annweiler G; Labriffe M; Ménager P; Ferland G; Brangier A; Annweiler C;
    Maturitas; 2020 Feb; 132():35-39. PubMed ID: 31883661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Factors Associated with Direct Oral Anticoagulants versus Vitamin K Antagonists in Patients with Non-valvular Atrial Fibrillation].
    Saliba L; Mondoly P; Duparc A; Bura-Rivière A; Maury P; Calmels V; Sallerin B; Pathak A; Montastruc JL; Bagheri H
    Therapie; 2015; 70(6):485-92. PubMed ID: 26223162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracranial complications after minor head injury (MHI) in patients taking vitamin K antagonists (VKA) or direct oral anticoagulants (DOACs).
    Riccardi A; Spinola B; Minuto P; Ghinatti M; Guiddo G; Malerba M; Lerza R
    Am J Emerg Med; 2017 Sep; 35(9):1317-1319. PubMed ID: 28400068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a tool to identify patients' preference for vitamin K antagonist or direct oral anticoagulant therapy.
    Zolfaghari S; Harenberg J; Froelich L; Wehling M; Weiss C
    Semin Thromb Hemost; 2014 Feb; 40(1):121-8. PubMed ID: 24381153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vitamin K antagonist, direct oral anticoagulants: Where is the truth?].
    Laroche JP; Schved JF
    J Mal Vasc; 2016 Dec; 41(6):383-388. PubMed ID: 27817997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke severity in patients with preceding direct oral anticoagulant therapy as compared to vitamin K antagonists.
    Auer E; Frey S; Kaesmacher J; Hakim A; Seiffge DJ; Goeldlin M; Arnold M; Fischer U; Jung S; Meinel TR
    J Neurol; 2019 Sep; 266(9):2263-2272. PubMed ID: 31165232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care Databases.
    Maura G; Billionnet C; Alla F; Gagne JJ; Pariente A
    Pharmacotherapy; 2018 Jan; 38(1):6-18. PubMed ID: 29028119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI characteristics in acute ischemic stroke patients with preceding direct oral anticoagulant therapy as compared to vitamin K antagonists.
    Meinel TR; Kaesmacher J; Gralla J; Seiffge DJ; Auer E; Frey S; El-Koussy M; Arnold M; Fischer U; Göldlin M; Jung S; Hakim A
    BMC Neurol; 2020 Mar; 20(1):86. PubMed ID: 32160909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome.
    Seiffge DJ; Hooff RJ; Nolte CH; Béjot Y; Turc G; Ikenberg B; Berge E; Persike M; Dequatre-Ponchelle N; Strbian D; Pfeilschifter W; Zini A; Tveiten A; Næss H; Michel P; Sztajzel R; Luft A; Gensicke H; Traenka C; Hert L; Scheitz JF; De Marchis GM; Bonati LH; Peters N; Charidimou A; Werring DJ; Palm F; Reinhard M; Niesen WD; Nagao T; Pezzini A; Caso V; Nederkoorn PJ; Kägi G; von Hessling A; Padjen V; Cordonnier C; Erdur H; Lyrer PA; Brouns R; Steiner T; Tatlisumak T; Engelter ST;
    Circulation; 2015 Sep; 132(13):1261-9. PubMed ID: 26232277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naïve patients with non-valvular atrial fibrillation: Propensity score matched cohort study.
    Denas G; Gennaro N; Ferroni E; Fedeli U; Saugo M; Zoppellaro G; Padayattil Jose S; Costa G; Corti MC; Andretta M; Pengo V
    Int J Cardiol; 2017 Dec; 249():198-203. PubMed ID: 28935464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage.
    Gerner ST; Kuramatsu JB; Sembill JA; Sprügel MI; Hagen M; Knappe RU; Endres M; Haeusler KG; Sobesky J; Schurig J; Zweynert S; Bauer M; Vajkoczy P; Ringleb PA; Purrucker JC; Rizos T; Volkmann J; Müllges W; Kraft P; Schubert AL; Erbguth F; Nueckel M; Schellinger PD; Glahn J; Knappe UJ; Fink GR; Dohmen C; Stetefeld H; Fisse AL; Minnerup J; Hagemann G; Rakers F; Reichmann H; Schneider H; Rahmig J; Ludolph AC; Stösser S; Neugebauer H; Röther J; Michels P; Schwarz M; Reimann G; Bäzner H; Schwert H; Claßen J; Michalski D; Grau A; Palm F; Urbanek C; Wöhrle JC; Alshammari F; Horn M; Bahner D; Witte OW; Günther A; Hamann GF; Engelhorn T; Lücking H; Dörfler A; Schwab S; Huttner HB
    Stroke; 2019 Jun; 50(6):1392-1402. PubMed ID: 31092170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet Therapy in Primary Spontaneous and Oral Anticoagulation-Associated Intracerebral Hemorrhage.
    Sprügel MI; Kuramatsu JB; Gerner ST; Sembill JA; Beuscher VD; Hagen M; Roeder SS; Lücking H; Struffert T; Dörfler A; Schwab S; Huttner HB
    Stroke; 2018 Nov; 49(11):2621-2629. PubMed ID: 30355188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vascular calcifications, the hidden side effects of vitamin K antagonists].
    Bennis Y; Vengadessane S; Bodeau S; Gras V; Bricca G; Kamel S; Liabeuf S
    Therapie; 2016 Sep; 71(4):355-63. PubMed ID: 27203170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of vitamin K antagonists and direct oral anticoagulation on coronary artery disease: A CTA analysis.
    Plank F; Beyer C; Friedrich G; Stühlinger M; Hintringer F; Dichtl W; Wildauer M; Feuchtner G
    Int J Cardiol; 2018 Jun; 260():11-15. PubMed ID: 29530620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Systematic Review and Meta-analysis of the Association Between Vitamin K Antagonist Use and Fracture.
    Fiordellisi W; White K; Schweizer M
    J Gen Intern Med; 2019 Feb; 34(2):304-311. PubMed ID: 30511289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Novel oral anticoagulants and atrial fibrillation in the elderly].
    Hanon O
    Geriatr Psychol Neuropsychiatr Vieil; 2013 Dec; 11(1 Suppl):34-40. PubMed ID: 24463062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy.
    De Caterina R; Brüggenjürgen B; Darius H; Köhler S; Lucerna M; Pecen L; Renda G; Schilling RJ; Schliephacke T; Zamorano JL; Le Heuzey JY; Kirchhof P
    Arch Cardiovasc Dis; 2018 Feb; 111(2):74-84. PubMed ID: 28942115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oral anticoagulation in atrial fibrillation: differential therapy with non vitamin K antagonist oral anticoagulants (NOAC) and vitamin K antagonists (VKA)].
    Sucker C; Litmathe J; Berthold HK
    MMW Fortschr Med; 2019 Oct; 161(Suppl 6):15-23. PubMed ID: 31587168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Which place for direct oral anticoagulants in routine hospital medical practice?].
    Khetta M; Benhamou Y; Tharasse C; Le Besnerais M; Miranda S; Cailleux-Talbot N; Girszyn N; Ngo S; Sauvêtre G; Lévesque H; Armengol G
    Rev Med Interne; 2015 Dec; 36(12):813-7. PubMed ID: 26320364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choice of New Oral Anticoagulant Agents Versus Vitamin K Antagonists in Atrial Fibrillation: FANTASIIA Study.
    Moreno-Arribas J; Bertomeu-González V; Anguita-Sanchez M; Cequier Á; Muñiz J; Castillo J; Sanchis J; Roldán I; Marín F; Bertomeu-Martínez V;
    J Cardiovasc Pharmacol Ther; 2016 Mar; 21(2):150-6. PubMed ID: 26229096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.